← Leaderboards
Michael James Keiser
Seachange Pharmaceuticals, Inc.
$933,052
Attributed
$1,663,603
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $757.4K · FY2010–14$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$1,663,603 · 4
By mechanism
R44$909,637 · 1
R43$753,966 · 3
Top collaborators
- Carl Nicholas Hodge4 shared
Most similar at Seachange Pharmaceuticals, Inc.
Same institution · by research overlap
- Carl Nicholas Hodge$730,552
Others in their field
Top investigators on “Ligands”
- John Damon Chodera · Sloan-Kettering Inst Can Research$39,009,297
- Keith W Miller · Massachusetts General Hospital$35,506,092
- Ian A Wilson · Scripps Research Institute, The$35,392,112
- Bryan L Roth · Univ Of North Carolina Chapel Hill$32,442,555
- Edward Franklin Plow · Cleveland Clinic Foundation$32,215,714
- Helen M Berman · Rutgers University New Brunswick$32,076,400
Research focus
LigandsPharmaceutical PreparationsSmall MoleculeDatabasesPublic Health RelevanceStagingMolecular TargetInterestLettersMapsBinding (Molecular Function)ProteinsReceptor BindingDesignAdverse EffectsDrug Delivery SystemsAnimalsDrug DiscoveryAffinityCollaborationsBaseInvestigational DrugsCardiovascular DiseasesBiology
Grant awards (5)
A platform to predict side-effect targets for drugs$453,470
R44 · FY2014 · GM
A platform to predict side-effect targets for drugs$456,167
R44 · FY2013 · GM
Relating GPCRs by biased ligands for enhanced therapeutic efficacy$301,225
R43 · FY2013 · MH · contact PI
Calculating target bias in small molecules for library design$250,241
R43 · FY2011 · GM · contact PI
Drug Repurposing using Pharmacological Networks$202,500
R43 · FY2010 · GM · contact PI